1. Janssen Pharmaceutica Nv (16 from 2,078 patents)

2. Furiex Pharmaceuticals, Inc. (4 from 4 patents)

3. Bristol-myers Squibb Pharma Company (2 from 234 patents)

4. Bristol-myers Squibb Compnay (1 from 3,684 patents)

5. Mitsubishi Tanabe Pharma Corporation (1 from 257 patents)

6. Allergan Holdings Unlimited Company (1 from 11 patents)

7. Forest Tosara Limited (1 from 1 patent)

1. 9789125 - Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid

2. 9464055 - Quinoline derivatives useful as CB-1 inverse agonists

3. 9434711 - Sulfonamides as TRPM8 modulators

4. 9364489 - Crystals and process of making 5-({[2-amino-3-(4-Carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid

5. 9303046 - Process for the preparation of heterocyclic ester derivatives

6. 9266835 - Quinoline derivatives useful as CB-1 inverse agonists

7. 9150532 - Fused cyclopentyl antagonists of CCR2

8. 9115091 - Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl—1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid

9. 9090639 - Cold menthol receptor-1 antagonists

10. 9056850 - Process for the preparation of compounds useful as inhibitors of SGLT

11. 9029352 - Process for the preparation of C-FMS kinase inhibitors

12. 8859604 - Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid

13. 8809327 - Sulfonamides as TRPM8 modulators

14. 8691860 - Crystals and process of making 5-({(2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(-4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid

15. 8680278 - Enantioselective process for preparing a substituted alkanoic acid